Agile Therapeutics, Inc. (AGRX)

Aug 26, 2024 - AGRX was delisted (reason: acquired by Insud Pharma)

1.510

0.00 (0.00%)

Inactive · Last trade price on Aug 26, 2024

Agile Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Revenue	21.57	19.59	10.88	4.1	0.75	-
Revenue Growth	32.22%	80.02%	165.40%	447.53%	-	-
Gross Profit	13.73	10.62	4.05	-6.62	0.47	-
Operating Income	-13.56	-19.88	-41.43	-71.01	-49.05	-18.86
Net Income	-15.86	-14.47	-25.41	-71.07	-51.85	-18.61
Earnings Per Share	-3.64	-6.71	-58.79	-1464.21	-1224.62	-752.79
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Investments	2.85	2.56	5.25	19.14	54.47	34.48
Total Debt	0.29	2.17	2.21	17.79	16.52	0.17
Net Cash (Debt)	2.56	0.39	3.04	1.35	37.95	34.31
Net Cash Growth	2712.09%	-87.31%	124.65%	-96.44%	10.63%	336.98%
Net Cash Per Share	0.59	0.18	7.02	27.84	896.32	1388.05

Cash Flow & CapEx

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Operating Cash Flow	-1.71	-9.58	-35.95	-65.2	-47.31	-15.69
Capital Expenditures	-	-	-0.13	-0.27	-0.35	-0.1
Free Cash Flow	-1.71	-9.58	-36.08	-65.47	-47.66	-15.79
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Gross Margin	63.63%	54.18%	37.19%	-161.35%	62.35%	-
Operating Margin	-62.85%	-101.49%	-380.69%	-1731.41%	-6549.13%	-
Pretax Margin	-73.52%	-73.83%	-276.43%	-1732.92%	-6922.96%	-
Profit Margin	-73.52%	-73.83%	-233.48%	-1732.92%	-6922.96%	-
FCF Margin	-7.91%	-48.88%	-331.50%	-1596.46%	-6363.68%	-

Valuation

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug '26 Aug 16, 2026	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
PS Ratio	0.31	0.25	0.85	14.45	335.03	-